US2016145347A1PendingUtilityA1

Anti-Prostate Cancer Antibodies and Methods of Detection and Treatment of Prostate Cancer

Assignee: UNIV PENNSYLVANIAPriority: Dec 16, 2009Filed: Dec 7, 2015Published: May 26, 2016

Est. expiryDec 16, 2029(~3.4 yrs left)· nominal 20-yr term from priority

Inventors:Mark I. Greene Hongtao Zhang Geng Zhang

A61P 35/04C07K 2317/732A61P 35/00C07K 2317/73C07K 16/3069C07K 2317/734G01N 33/57557G01N 33/57555

PatentIndex Score

Cited by

References

Claims

Abstract

Disclosed herein are antibodies that detect a lipid-like antigen on prostate cancer cells and methods of detecting and treating prostate cancer using the same.

Claims

exact text as granted — not AI-modified

1 .- 21 . (canceled) 
     
     
         22 . An antibody or antibody functional fragment that binds to B-III dodecaosylceramide or B-IV tetradecaosylceramide; provided that the antibody is not F77 MAb. 
     
     
         23 . The antibody or antibody functional fragment of  claim 22  wherein said antibody or antibody functional fragment competes for binding with F77 MAb. 
     
     
         24 . The antibody or antibody functional fragment of  claim 23  wherein said antibody or antibody functional fragment competes for binding with F77 MAb to B-III dodecaosylceramide or B-IV tetradecaosylceramide. 
     
     
         25 .- 33 . (canceled)

Join the waitlist — get patent alerts

Track US2016145347A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.